Methylenetetrahydrofolate reductase (MTHFR)

The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population

Peter L. Rady, Stephen K. Tyring, S. David Hudnall, Trini Vargas, Leonard H. Kellner, Harold Nitowsky, Reuben Matalon

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The polymorphic mutation C677T in the gene of MTHFR is considered a risk mutation for spina bifida and vascular disease. Another common mutation on the MTHFR gene, A1298C, has also been described as another risk mutation. We studied the frequencies of these two mutations on DNA samples from healthy Jewish individuals and compared them to the frequency of these mutations in DNA samples obtained from healthy individuals in South Texas. The presence of the C677T allele was determined by PCR and HinfI digestion, and mutation A1298C by PCR and Mbo II digestion. A total of 310 alleles was examined for C677T in the Ashkenazi samples and 400 alleles in the non-Jewish samples. The rate of C677T among the Ashkenazi Jewish alleles was 47.7% as compared to 28.7% among the alleles from the non-Jewish population. The difference is statistically significant, P < 0.0005. Mutation A1298C was examined in 298 alleles of Jewish individuals and 374 alleles of non-Jewish counterparts from Texas. The rate of the A1298C mutation in the Jewish samples was 27.2% whereas in the non-Jewish was 35%. This was also statistically significant, P < 0.031. No individuals were homozygous for both mutations or were found to be homozygous for one mutation with heterozygosity of the other mutation, and that the C677T and the A1298C alleles did not occur in cis position. This study shows a unique distribution of C677T and the A1298C alleles among the Ashkenazi Jews. In spite of high frequency of C677T mutation, spina bifida is less common among Ashkenazi Jews. Further studies are needed to establish whether the C677T and the A1298C mutations have an impact on vascular disease in the Ashkenazi Jewish population.

Original languageEnglish (US)
Pages (from-to)380-384
Number of pages5
JournalAmerican Journal of Medical Genetics
Volume86
Issue number4
DOIs
StatePublished - 1999

Fingerprint

Methylenetetrahydrofolate Reductase (NADPH2)
Alleles
Mutation
Incidence
Population
Mutation Rate
Jews
Spinal Dysraphism
Vascular Diseases
Digestion
Polymerase Chain Reaction
DNA
Genes

Keywords

  • Ashkenazi Jews
  • MTHFR
  • Polymorphism
  • Risk mutations

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Methylenetetrahydrofolate reductase (MTHFR) : The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. / Rady, Peter L.; Tyring, Stephen K.; Hudnall, S. David; Vargas, Trini; Kellner, Leonard H.; Nitowsky, Harold; Matalon, Reuben.

In: American Journal of Medical Genetics, Vol. 86, No. 4, 1999, p. 380-384.

Research output: Contribution to journalArticle

Rady, Peter L. ; Tyring, Stephen K. ; Hudnall, S. David ; Vargas, Trini ; Kellner, Leonard H. ; Nitowsky, Harold ; Matalon, Reuben. / Methylenetetrahydrofolate reductase (MTHFR) : The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. In: American Journal of Medical Genetics. 1999 ; Vol. 86, No. 4. pp. 380-384.
@article{0b74a8495b374bcdba387f65da00b729,
title = "Methylenetetrahydrofolate reductase (MTHFR): The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population",
abstract = "The polymorphic mutation C677T in the gene of MTHFR is considered a risk mutation for spina bifida and vascular disease. Another common mutation on the MTHFR gene, A1298C, has also been described as another risk mutation. We studied the frequencies of these two mutations on DNA samples from healthy Jewish individuals and compared them to the frequency of these mutations in DNA samples obtained from healthy individuals in South Texas. The presence of the C677T allele was determined by PCR and HinfI digestion, and mutation A1298C by PCR and Mbo II digestion. A total of 310 alleles was examined for C677T in the Ashkenazi samples and 400 alleles in the non-Jewish samples. The rate of C677T among the Ashkenazi Jewish alleles was 47.7{\%} as compared to 28.7{\%} among the alleles from the non-Jewish population. The difference is statistically significant, P < 0.0005. Mutation A1298C was examined in 298 alleles of Jewish individuals and 374 alleles of non-Jewish counterparts from Texas. The rate of the A1298C mutation in the Jewish samples was 27.2{\%} whereas in the non-Jewish was 35{\%}. This was also statistically significant, P < 0.031. No individuals were homozygous for both mutations or were found to be homozygous for one mutation with heterozygosity of the other mutation, and that the C677T and the A1298C alleles did not occur in cis position. This study shows a unique distribution of C677T and the A1298C alleles among the Ashkenazi Jews. In spite of high frequency of C677T mutation, spina bifida is less common among Ashkenazi Jews. Further studies are needed to establish whether the C677T and the A1298C mutations have an impact on vascular disease in the Ashkenazi Jewish population.",
keywords = "Ashkenazi Jews, MTHFR, Polymorphism, Risk mutations",
author = "Rady, {Peter L.} and Tyring, {Stephen K.} and Hudnall, {S. David} and Trini Vargas and Kellner, {Leonard H.} and Harold Nitowsky and Reuben Matalon",
year = "1999",
doi = "10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9",
language = "English (US)",
volume = "86",
pages = "380--384",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Methylenetetrahydrofolate reductase (MTHFR)

T2 - The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population

AU - Rady, Peter L.

AU - Tyring, Stephen K.

AU - Hudnall, S. David

AU - Vargas, Trini

AU - Kellner, Leonard H.

AU - Nitowsky, Harold

AU - Matalon, Reuben

PY - 1999

Y1 - 1999

N2 - The polymorphic mutation C677T in the gene of MTHFR is considered a risk mutation for spina bifida and vascular disease. Another common mutation on the MTHFR gene, A1298C, has also been described as another risk mutation. We studied the frequencies of these two mutations on DNA samples from healthy Jewish individuals and compared them to the frequency of these mutations in DNA samples obtained from healthy individuals in South Texas. The presence of the C677T allele was determined by PCR and HinfI digestion, and mutation A1298C by PCR and Mbo II digestion. A total of 310 alleles was examined for C677T in the Ashkenazi samples and 400 alleles in the non-Jewish samples. The rate of C677T among the Ashkenazi Jewish alleles was 47.7% as compared to 28.7% among the alleles from the non-Jewish population. The difference is statistically significant, P < 0.0005. Mutation A1298C was examined in 298 alleles of Jewish individuals and 374 alleles of non-Jewish counterparts from Texas. The rate of the A1298C mutation in the Jewish samples was 27.2% whereas in the non-Jewish was 35%. This was also statistically significant, P < 0.031. No individuals were homozygous for both mutations or were found to be homozygous for one mutation with heterozygosity of the other mutation, and that the C677T and the A1298C alleles did not occur in cis position. This study shows a unique distribution of C677T and the A1298C alleles among the Ashkenazi Jews. In spite of high frequency of C677T mutation, spina bifida is less common among Ashkenazi Jews. Further studies are needed to establish whether the C677T and the A1298C mutations have an impact on vascular disease in the Ashkenazi Jewish population.

AB - The polymorphic mutation C677T in the gene of MTHFR is considered a risk mutation for spina bifida and vascular disease. Another common mutation on the MTHFR gene, A1298C, has also been described as another risk mutation. We studied the frequencies of these two mutations on DNA samples from healthy Jewish individuals and compared them to the frequency of these mutations in DNA samples obtained from healthy individuals in South Texas. The presence of the C677T allele was determined by PCR and HinfI digestion, and mutation A1298C by PCR and Mbo II digestion. A total of 310 alleles was examined for C677T in the Ashkenazi samples and 400 alleles in the non-Jewish samples. The rate of C677T among the Ashkenazi Jewish alleles was 47.7% as compared to 28.7% among the alleles from the non-Jewish population. The difference is statistically significant, P < 0.0005. Mutation A1298C was examined in 298 alleles of Jewish individuals and 374 alleles of non-Jewish counterparts from Texas. The rate of the A1298C mutation in the Jewish samples was 27.2% whereas in the non-Jewish was 35%. This was also statistically significant, P < 0.031. No individuals were homozygous for both mutations or were found to be homozygous for one mutation with heterozygosity of the other mutation, and that the C677T and the A1298C alleles did not occur in cis position. This study shows a unique distribution of C677T and the A1298C alleles among the Ashkenazi Jews. In spite of high frequency of C677T mutation, spina bifida is less common among Ashkenazi Jews. Further studies are needed to establish whether the C677T and the A1298C mutations have an impact on vascular disease in the Ashkenazi Jewish population.

KW - Ashkenazi Jews

KW - MTHFR

KW - Polymorphism

KW - Risk mutations

UR - http://www.scopus.com/inward/record.url?scp=0032822750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032822750&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9

DO - 10.1002/(SICI)1096-8628(19991008)86:4<380::AID-AJMG13>3.0.CO;2-9

M3 - Article

VL - 86

SP - 380

EP - 384

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 4

ER -